Lipoxygenase inhibition: the neglected frontier for regulating chronic inflammation and pain

Author： Whitehouse M.   Rainsford K.  

Publisher： Springer Publishing Company

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.14, Iss.3-4, 2006-08, pp. : 99-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of 5-lipoxygenase and cyclooxygenase-2 pathways by pain-relieving plaster in macrophages

By Peng Shan-Ying   Liu Yang   Bao Xu-hong   Wang Lin   Zhang Fu-ying   Wang Feng   Wang Wen-jie  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 49, Iss. 7, 2011-07 ,pp. : 716-726

Informa Healthcare

Access to resources Recommend Favorite

Tackling Chronic Pain and Inflammation through the Purinergic System

By  

Current Medicinal Chemistry, Vol. 25, Iss. 32, 2018-10 ,pp. : 3830-3865

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Prokineticin System to Control Chronic Pain and Inflammation

By  

Current Medicinal Chemistry, Vol. 25, Iss. 32, 2018-10 ,pp. : 3883-3894

Bentham Science Publishers

Access to resources Recommend Favorite

New Targets for Treating Chronic Pain and Inflammation

By  

Current Medicinal Chemistry, Vol. 25, Iss. 32, 2018-10 ,pp. : 3828-3829

Bentham Science Publishers

Access to resources Recommend Favorite

Fractalkine/CX3CR1 Signalling in Chronic Pain and Inflammation

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. : 1707-1714

Bentham Science Publishers

Access to resources Recommend Favorite